| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1074248416679733 |
| P698 | PubMed publication ID | 28196437 |
| P2093 | author name string | Bernard Chaitman | |
| Robert A Kloner | |||
| P2860 | cites work | Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial | Q46802477 |
| Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year | Q47580358 | ||
| Stress Testing After Complete and Successful Coronary Revascularization. | Q47783419 | ||
| Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease). | Q50966449 | ||
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart | Q52956605 | ||
| Ivabradine in stable coronary artery disease without clinical heart failure. | Q53262277 | ||
| Health status predicts long-term outcome in outpatients with coronary disease. | Q53428381 | ||
| Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina. | Q54026944 | ||
| Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme | Q57396157 | ||
| Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion?: A Systematic Review & Meta-Analysis | Q26752458 | ||
| Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials | Q28260825 | ||
| Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial | Q30842618 | ||
| A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions | Q31059180 | ||
| Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial | Q33200904 | ||
| Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris | Q33202332 | ||
| A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease | Q33227138 | ||
| A Systematic Review on the Short-term Efficacy and Safety of Nicorandil for Stable Angina Pectoris in Comparison with Those of β-Blockers, Nitrates and Calcium Antagonists | Q33737301 | ||
| Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial | Q34124712 | ||
| Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study) | Q34175141 | ||
| Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study | Q34235650 | ||
| Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease | Q34353605 | ||
| Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial | Q34544699 | ||
| Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina | Q34547211 | ||
| Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial | Q34569443 | ||
| Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial | Q34578958 | ||
| Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 | ||
| Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial | Q35810820 | ||
| Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial | Q37112685 | ||
| Efficacy of Enhanced External Counterpulsation in Patients With Chronic Refractory Angina on Canadian Cardiovascular Society (CCS) Angina Class: An Updated Meta-Analysis | Q37328519 | ||
| Stable angina pectoris: antianginal therapies and future directions | Q37924086 | ||
| Persistent angina: the Araba Phoenix of cardiology. | Q39293783 | ||
| Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina | Q39323194 | ||
| Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. | Q39401297 | ||
| Autologous CD34+ Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study | Q39790202 | ||
| Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial | Q44319414 | ||
| Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. | Q44568094 | ||
| Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans. | Q45168063 | ||
| Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study | Q45232317 | ||
| Remote Ischemic Conditioning: Its Benefits and Limitations | Q45292422 | ||
| Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr | Q46038950 | ||
| Effect of PCI on quality of life in patients with stable coronary disease | Q46429326 | ||
| Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes | Q46715059 | ||
| Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis | Q46776387 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 199-209 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology and Therapeutics | Q1855644 |
| P1476 | title | Angina and Its Management | |
| P478 | volume | 22 |
| Q99590788 | Effect of hypercholesterolemia alone or combined with hypertension on the degree of coronary artery stenosis in patients with coronary heart disease angina pectoris: A medical records based retrospective study protocol |
| Q95591345 | Gastrointestinal pain |
| Q90258283 | Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice? |
Search more.